ENSYSCE BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $693 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-30
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $693.00, a 0.14% increase from fiscal 2024.
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $692.00, a 99.10% decline from fiscal 2023.
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $77.16K.
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$78.23K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $693.00 10-K · filed 2026-03-30 | |
| 2024-12-31 | $692.00 10-K · filed 2026-03-30 | $11.28K 10-K · filed 2025-03-10 |
| 2023-12-31 | $77.16K 10-K · filed 2025-03-10 | |
| 2022-12-31 | -$78.23K 10-K · filed 2024-03-15 | |
| 2021-12-31 | -$139.21K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $405.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |